ZACCARDELLI DAVID purchased 615.4% of their position (40K shares) of MELINTA THERAPEUTICS, INC. /NEW/ on the open market
Open‑market purchase worth $200.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/31/2018ACC: 0000899243-18-014565
Director
Since Jun 2019
+40K
Net shares
Net buyer
$200.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40K
Price / share
$5.00
Trade value
$200K
% of position
615.4%
5/29/2018
6.50K→46.50K
Total
Net shares
+40K
Net value
$200K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2018 | P · Purchase | +40K | $5.00 | $200K | 615.4% | 6.50K | 46.50K |
| Total | +40K | $200K | ||||||
Derivative Transactions0
No derivative transactions reported